Cameroon vs Congo: Treatment success rate for patients treated for MDR-TB
Cameroon
82.0%
in 2022
Congo
83.0%
in 2022
Cameroon rank
44th
Congo rank
42nd
Treatment success rate for patients treated for MDR-TB over time
- Cameroon
- Congo
How they compare
Congo currently reports 83.0% against 82.0% in Cameroon, a difference of 1.0%.
The two have swapped places 3 times across 7 shared years of data; in 2015 it was Cameroon ahead.
Cameroon ranks 44th and Congo ranks 42nd of 163 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.8% | 78.0% | 4.8% | Cameroon |
| 2020s | 79.7% | 71.7% | 8.0% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cameroon or Congo?
- Congo, at 83.0% against 82.0% in Cameroon as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cameroon and Congo?
- 1.0%, with Congo ahead.
- How many years of comparable data are there for Cameroon and Congo?
- 7 years are reported by both, from 2015 to 2022.
- How do Cameroon and Congo rank globally for treatment success rate for patients treated for mdr-tb?
- Cameroon ranks 44th and Congo ranks 42nd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.